NESS ZIONA, Israel, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today ...
Sol-Gel Technologies (SLGL) fell ~10% in the premarket on Wednesday after the dermatological drug developer announced that unfavorable data from an early-stage trial had prompted it to halt further ...
Sol-Gel Technologies’ work to expand the treatment options for patients with the skin condition rosacea has paid off, with the FDA approving a product based on its microencapsulation technology.
NESS ZIONA, Israel, March 20, 2023 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company with two innovative dermatology products that were launched in the U.S. and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback